237 related articles for article (PubMed ID: 8981387)
1. Haloperidol- and clozapine-induced enhancement of latent inhibition with extended conditioning: implications for the mechanism of action of neuroleptic drugs.
Weiner I; Shadach E; Barkai R; Feldon J
Neuropsychopharmacology; 1997 Jan; 16(1):42-50. PubMed ID: 8981387
[TBL] [Abstract][Full Text] [Related]
2. Systemic administration of MK-801 produces an abnormally persistent latent inhibition which is reversed by clozapine but not haloperidol.
Gaisler-Salomon I; Weiner I
Psychopharmacology (Berl); 2003 Apr; 166(4):333-42. PubMed ID: 12599023
[TBL] [Abstract][Full Text] [Related]
3. The latent inhibition model of schizophrenia: further validation using the atypical neuroleptic, clozapine.
Weiner I; Shadach E; Tarrasch R; Kidron R; Feldon J
Biol Psychiatry; 1996 Nov; 40(9):834-43. PubMed ID: 8896769
[TBL] [Abstract][Full Text] [Related]
4. The sigma ligand BMY-14802 as a potential antipsychotic: evidence from the latent inhibition model in rats.
Weiner I; Traub A; Rawlins JN; Smith AD; Feldon J
Behav Pharmacol; 1995 Jan; 6(1):46-54. PubMed ID: 11224311
[TBL] [Abstract][Full Text] [Related]
5. The latent inhibition model dissociates between clozapine, haloperidol, and ritanserin.
Shadach E; Gaisler I; Schiller D; Weiner I
Neuropsychopharmacology; 2000 Aug; 23(2):151-61. PubMed ID: 10882841
[TBL] [Abstract][Full Text] [Related]
6. Amphetamine-induced disruption and haloperidol-induced potentiation of latent inhibition depend on the nature of the stimulus.
Ruob C; Elsner J; Weiner I; Feldon J
Behav Brain Res; 1997 Oct; 88(1):35-41. PubMed ID: 9401706
[TBL] [Abstract][Full Text] [Related]
7. Clozapine and haloperidol reinstate latent inhibition following its disruption during amphetamine withdrawal.
Russig H; Murphy CA; Feldon J
Neuropsychopharmacology; 2002 Jun; 26(6):765-77. PubMed ID: 12007747
[TBL] [Abstract][Full Text] [Related]
8. Disruption and potentiation of latent inhibition by risperidone: the latent inhibition model of atypical antipsychotic action.
Weiner I; Schiller D; Gaisler-Salomon I
Neuropsychopharmacology; 2003 Mar; 28(3):499-509. PubMed ID: 12629529
[TBL] [Abstract][Full Text] [Related]
9. The latent inhibition model of schizophrenic attention disorder. Haloperidol and sulpiride enhance rats' ability to ignore irrelevant stimuli.
Feldon J; Weiner I
Biol Psychiatry; 1991 Apr; 29(7):635-46. PubMed ID: 2054435
[TBL] [Abstract][Full Text] [Related]
10. Haloperidol-induced potentiation of latent inhibition: interaction with parameters of conditioning.
Ruob C; Weiner I; Feldon J
Behav Pharmacol; 1998 May; 9(3):245-53. PubMed ID: 9832938
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of latent inhibition in the rat at a high dose of clozapine.
Trimble KM; Bell R; King DJ
J Psychopharmacol; 1998; 12(2):215-9. PubMed ID: 9694034
[TBL] [Abstract][Full Text] [Related]
12. Abnormally persistent latent inhibition induced by lesions to the nucleus accumbens core, basolateral amygdala and orbitofrontal cortex is reversed by clozapine but not by haloperidol.
Schiller D; Zuckerman L; Weiner I
J Psychiatr Res; 2006 Mar; 40(2):167-77. PubMed ID: 15882871
[TBL] [Abstract][Full Text] [Related]
13. Latent inhibition in 35-day-old rats is not an "adult" latent inhibition: implications for neurodevelopmental models of schizophrenia.
Zuckerman L; Rimmerman N; Weiner I
Psychopharmacology (Berl); 2003 Sep; 169(3-4):298-307. PubMed ID: 12827344
[TBL] [Abstract][Full Text] [Related]
14. Facilitation of the expression but not the acquisition of latent inhibition by haloperidol in rats.
Weiner I; Feldon J; Katz Y
Pharmacol Biochem Behav; 1987 Feb; 26(2):241-6. PubMed ID: 3575349
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of latent inhibition in the rat by the atypical antipsychotic agent remoxipride.
Trimble KM; Bell R; King DJ
Pharmacol Biochem Behav; 1997 Apr; 56(4):809-16. PubMed ID: 9130309
[TBL] [Abstract][Full Text] [Related]
16. Antagonism of amphetamine-induced disruption of latent inhibition in rats by haloperidol and ondansetron: implications for a possible antipsychotic action of ondansetron.
Warburton EC; Joseph MH; Feldon J; Weiner I; Gray JA
Psychopharmacology (Berl); 1994 May; 114(4):657-64. PubMed ID: 7855229
[TBL] [Abstract][Full Text] [Related]
17. Haloperidol and clozapine antagonise amphetamine-induced disruption of latent inhibition of conditioned taste aversion.
Russig H; Kovacevic A; Murphy CA; Feldon J
Psychopharmacology (Berl); 2003 Nov; 170(3):263-270. PubMed ID: 12898122
[TBL] [Abstract][Full Text] [Related]
18. Facilitation of latent inhibition by haloperidol in rats.
Weiner I; Feldon J
Psychopharmacology (Berl); 1987; 91(2):248-53. PubMed ID: 3107041
[TBL] [Abstract][Full Text] [Related]
19. Effects of microinjections of apomorphine and haloperidol into the inferior colliculus on the latent inhibition of the conditioned emotional response.
Melo LL; Pereira EC; Pagini CH; Coimbra NC; Brandão ML; Ferrari EA
Exp Neurol; 2009 Mar; 216(1):16-21. PubMed ID: 19084523
[TBL] [Abstract][Full Text] [Related]
20. Early handling and latent inhibition in the conditioned suppression paradigm.
Weiner I; Feldon J; Ziv-Harris D
Dev Psychobiol; 1987 Mar; 20(2):233-40. PubMed ID: 3582782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
